Authors
Tao Wang, Matthew S Dowling, Dahui Zhou, David Jonathan Wasilko, Meihua Tu, Denis Feliers, Barbara Bernardo, Joseph Tillotson, Wenzhe Ma, Janice Brown, Zachary Johnson, Joshua A Lees, Andrew Fensome, Andre Shavnya, Jennifer Clemens, Steven Coffey, Caroline A Blakemore, Melissa Avery, Jamison B Tuttle, Phillip Hudson, Magdalena Korczynska, John Murray, Jade Williams, Jun Xiao, Jason Dutra, Dianne Hernandez, Kevin D Hesp, Vincent Mascitti, Srinath Jagarlapudi, Rose Keenan, Jessica Ward, Robert Barnes, Emily Jordan, Natalie Ochocki, Daniel Callahan, Kimberly Steen, Amit S Kalgutkar, Kari R Fonseca, Raman Sharma, Nicholas Ferguson, Amanda King-Ahmad, Andrew J Bessire, Amy Moody, Tristan S Maurer, Ingrid A Stock, Ruth Sommese, Tracy Phillips, Paula M Loria, Huixian Wu, David Hepworth, Matthew F Sammons, Lei Zhang, Yuan Zhang
Published in
Journal of medicinal chemistry. Volume 69. Issue 21. Pages 26102-26115. Nov 12, 2026.
Abstract
SLC6A19 is a sodium-dependent transporter that mediates the absorption of neutral amino acids in the intestine and reabsorption of these amino acids in the kidney. Pharmacological inhibition of SLC6A19 may provide therapeutic benefit by normalizing plasma amino acid levels and potentially reducing renal tubular transport burden. Virtual screening against an allosteric binding pocket observed in the cryo-EM structure of SLC6A19/cinromide (1) identified compound 6 as a promising hit. The cryo-EM structure of SLC6A19/CB3 (2) revealed a second, partially overlapping pocket adjacent to the compound 6 binding site. Analogue design merging these two binding pockets followed by optimization led to compound 20, a potent, selective, and orally bioavailable allosteric SLC6A19 inhibitor. While compound 20 demonstrates an approximately 10-fold rightward potency shift against mouse SLC6A19, it retains good potency against non-human primate SLC6A19. Consistent with the SLC6A19 inhibition mechanism, oral dosing of 20 led to increased urinary amino acid excretion in a dose-dependent manner in human SLC6A19 knock-in mice and wild-type non-human primates.
PMID:
43018553
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0